Corrigendum to "Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents" [Eur. J. Med. Chem. 152 (2018) 148-159].

Eur J Med Chem

Medicinal & Process Chemistry Division, CSIR-Central Drug Research Institute, Sector-10, Jankipuram Extension, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110025, India; Medicinal Chemistry and Biotechnology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500007, India. Electronic address:

Published: August 2018

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2018.07.034DOI Listing

Publication Analysis

Top Keywords

corrigendum "identification
4
"identification novel
4
novel β-lactams
4
β-lactams pyrrolidinone
4
pyrrolidinone derivatives
4
derivatives selective
4
selective histamine-3
4
histamine-3 receptor
4
receptor h3r
4
h3r modulators
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!